Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
10.48
+0.29 (2.85%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +33.59% | Oct 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $12 | Buy | Maintains | $12 | +14.50% | Sep 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | -4.58% | Sep 21, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $18 | Buy | Reiterates | $18 | +71.76% | Sep 10, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $8 | Hold | Reiterates | $8 | -23.66% | Sep 10, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $12 → $16 | Buy | Reiterates | $12 → $16 | +52.67% | Sep 10, 2026 |